▶ 調査レポート

世界のアンチ毒産業2020-2026

• 英文タイトル:Global Antivenom Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界のアンチ毒産業2020-2026 / Global Antivenom Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3010999資料のイメージです。• レポートコード:D0MA3010999
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥539,000 (USD4,900)▷ お問い合わせ
  Multi User¥808,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,078,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、アンチ毒の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、アンチ毒のグローバル市場動向、メーカー別競争状況、種類別市場規模(多価抗毒素、一価抗毒素)、用途別市場規模(小売薬局、病院、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・アンチ毒の種類別市場2015-2026:多価抗毒素、一価抗毒素
・アンチ毒の用途別市場2015-2026:小売薬局、病院、その他
・アンチ毒の北米市場分析
・アンチ毒のアジア市場分析
・アンチ毒の中南米市場分析
・アンチ毒の中東・アフリカ市場分析
・関連企業情報:CSL Behring、Merck & Co.、BTG Plc、Pfizer、Haffkine Bio-Pharmaceutical Corporation、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.
In 2019, the global Antivenom market size was US$ 873.6 million and is forecast to US$ 1047.7 million in 2026, growing at a CAGR of 2.6% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Antivenom.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Antivenom market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Antivenom market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Antivenom market. Readers of the report can become informed about current and future trends of the global Antivenom market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Antivenom markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Antivenom market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Antivenom market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Antivenom market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Antivenom market is segmented into
Polyvalent antivenom
Monovalent antivenom

Market Segment by Application, the Antivenom market is segmented into
Retail Pharmacies
Hospitals
Others

This report includes the following manufacturers; we can also add the other companies as you want.
CSL Behring
Merck & Co.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech

The study objectives are:
To analyze and research the global Antivenom status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Antivenom manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antivenom are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Antivenom Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Antivenom Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Polyvalent antivenom
1.3.3 Monovalent antivenom
1.4 Market Segment by Application
1.4.1 Global Antivenom Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Retail Pharmacies
1.4.3 Hospitals
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Antivenom Revenue (2015-2026)
2.1.1 Global Antivenom Revenue (2015-2026)
2.1.2 Global Antivenom Sales (2015-2026)
2.2 Antivenom Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Antivenom Sales by Regions (2015-2020)
2.2.2 Global Antivenom Revenue by Regions (2015-2020)
2.3 Global Top Antivenom Regions (Countries) Ranking by Market Size
2.4 Antivenom Industry Trends
2.4.1 Antivenom Market Top Trends
2.4.2 Market Drivers
2.4.3 Antivenom Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Antivenom Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Antivenom Manufacturers by Sales (2015-2020)
3.1.1 Global Antivenom Sales by Manufacturers (2015-2020)
3.1.2 Global Antivenom Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Antivenom Sales in 2019
3.2 Global Top Manufacturers Antivenom by Revenue
3.2.1 Global Antivenom Revenue by Manufacturers (2015-2020)
3.2.2 Global Antivenom Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antivenom Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom as of 2019)
3.4 Global Antivenom Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antivenom Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antivenom Market
3.7 Key Manufacturers Antivenom Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Antivenom Historic Market Review by Type (2015-2020)
4.1.2 Global Antivenom Sales Market Share by Type (2015-2020)
4.1.3 Global Antivenom Revenue Market Share by Type (2015-2020)
4.1.4 Antivenom Price by Type (2015-2020)
4.1 Global Antivenom Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Antivenom Sales Forecast by Type (2021-2026)
4.2.3 Global Antivenom Revenue Forecast by Type (2021-2026)
4.2.4 Antivenom Price Forecast by Type (2021-2026)

5 Global Antivenom Market Size by Application
5.1 Global Antivenom Historic Market Review by Application (2015-2020)
5.1.2 Global Antivenom Sales Market Share by Application (2015-2020)
5.1.3 Global Antivenom Revenue Market Share by Application (2015-2020)
5.1.4 Antivenom Price by Application (2015-2020)
5.2 Global Antivenom Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Antivenom Sales Forecast by Application (2021-2026)
5.2.3 Global Antivenom Revenue Forecast by Application (2021-2026)
5.2.4 Antivenom Price Forecast by Application (2021-2026)

6 North America
6.1 North America Antivenom Breakdown Data by Company
6.2 North America Antivenom Breakdown Data by Type
6.3 North America Antivenom Breakdown Data by Application
6.4 North America Antivenom Breakdown Data by Countries
6.4.1 North America Antivenom Sales by Countries
6.4.2 North America Antivenom Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Antivenom Breakdown Data by Company
7.2 Europe Antivenom Breakdown Data by Type
7.3 Europe Antivenom Breakdown Data by Application
7.4 Europe Antivenom Breakdown Data by Countries
7.4.1 Europe Antivenom Sales by Countries
7.4.2 Europe Antivenom Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Antivenom Breakdown Data by Company
8.2 Asia Pacific Antivenom Breakdown Data by Type
8.3 Asia Pacific Antivenom Breakdown Data by Application
8.4 Asia Pacific Antivenom Breakdown Data by Regions
8.4.1 Asia Pacific Antivenom Sales by Regions
8.4.2 Asia Pacific Antivenom Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Antivenom Breakdown Data by Company
9.2 Latin America Antivenom Breakdown Data by Type
9.3 Latin America Antivenom Breakdown Data by Application
9.4 Latin America Antivenom Breakdown Data by Countries
9.4.1 Latin America Antivenom Sales by Countries
9.4.2 Latin America Antivenom Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Antivenom Breakdown Data by Type
10.2 Middle East and Africa Antivenom Breakdown Data by Application
10.3 Middle East and Africa Antivenom Breakdown Data by Countries
10.3.1 Middle East and Africa Antivenom Sales by Countries
10.3.2 Middle East and Africa Antivenom Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Business Overview and Total Revenue (2019 VS 2018)
11.1.3 CSL Behring Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 CSL Behring Antivenom Products and Services
11.1.5 CSL Behring SWOT Analysis
11.1.6 CSL Behring Recent Developments
11.2 Merck & Co.
11.2.1 Merck & Co. Corporation Information
11.2.2 Merck & Co. Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Merck & Co. Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Merck & Co. Antivenom Products and Services
11.2.5 Merck & Co. SWOT Analysis
11.2.6 Merck & Co. Recent Developments
11.3 BTG Plc
11.3.1 BTG Plc Corporation Information
11.3.2 BTG Plc Business Overview and Total Revenue (2019 VS 2018)
11.3.3 BTG Plc Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 BTG Plc Antivenom Products and Services
11.3.5 BTG Plc SWOT Analysis
11.3.6 BTG Plc Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Pfizer Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Pfizer Antivenom Products and Services
11.4.5 Pfizer SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Haffkine Bio-Pharmaceutical Corporation
11.5.1 Haffkine Bio-Pharmaceutical Corporation Corporation Information
11.5.2 Haffkine Bio-Pharmaceutical Corporation Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Haffkine Bio-Pharmaceutical Corporation Antivenom Products and Services
11.5.5 Haffkine Bio-Pharmaceutical Corporation SWOT Analysis
11.5.6 Haffkine Bio-Pharmaceutical Corporation Recent Developments
11.6 Rare Disease Therapeutics
11.6.1 Rare Disease Therapeutics Corporation Information
11.6.2 Rare Disease Therapeutics Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Rare Disease Therapeutics Antivenom Products and Services
11.6.5 Rare Disease Therapeutics SWOT Analysis
11.6.6 Rare Disease Therapeutics Recent Developments
11.7 Flynn Pharma
11.7.1 Flynn Pharma Corporation Information
11.7.2 Flynn Pharma Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Flynn Pharma Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Flynn Pharma Antivenom Products and Services
11.7.5 Flynn Pharma SWOT Analysis
11.7.6 Flynn Pharma Recent Developments
11.8 Vins Bioproducts
11.8.1 Vins Bioproducts Corporation Information
11.8.2 Vins Bioproducts Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Vins Bioproducts Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Vins Bioproducts Antivenom Products and Services
11.8.5 Vins Bioproducts SWOT Analysis
11.8.6 Vins Bioproducts Recent Developments
11.9 Bharat Serums and Vaccines
11.9.1 Bharat Serums and Vaccines Corporation Information
11.9.2 Bharat Serums and Vaccines Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Bharat Serums and Vaccines Antivenom Products and Services
11.9.5 Bharat Serums and Vaccines SWOT Analysis
11.9.6 Bharat Serums and Vaccines Recent Developments
11.10 Serum Biotech
11.10.1 Serum Biotech Corporation Information
11.10.2 Serum Biotech Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Serum Biotech Antivenom Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Serum Biotech Antivenom Products and Services
11.10.5 Serum Biotech SWOT Analysis
11.10.6 Serum Biotech Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Antivenom Sales Channels
12.2.2 Antivenom Distributors
12.3 Antivenom Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Antivenom Sales Forecast (2021-2026)
13.1.1 Global Antivenom Sales Forecast by Regions (2021-2026)
13.1.2 Global Antivenom Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Antivenom Sales Forecast (2021-2026)
13.2.2 North America Antivenom Revenue Forecast (2021-2026)
13.2.3 North America Antivenom Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Antivenom Sales Forecast (2021-2026)
13.3.2 Europe Antivenom Revenue Forecast (2021-2026)
13.3.3 Europe Antivenom Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Antivenom Sales Forecast (2021-2026)
13.4.2 Asia Pacific Antivenom Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Antivenom Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Antivenom Sales Forecast (2021-2026)
13.5.2 Latin America Antivenom Revenue Forecast (2021-2026)
13.5.3 Latin America Antivenom Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Antivenom Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Antivenom Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Antivenom Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Antivenom Key Market Segments
Table 2. Ranking of Global Top Antivenom Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antivenom Market Size Growth Rate by Type 2021-2026 (K Vials) & (Million US$)
Table 4. Major Manufacturers of Polyvalent antivenom
Table 5. Major Manufacturers of Monovalent antivenom
Table 6. Global Antivenom Market Share by Application 2019-2025 (K Vials)
Table 7. Global Antivenom Market Size by Regions 2015-2020 (K Vials) & (Million US$)
Table 8. Global Antivenom Sales by Regions 2015-2020 (K Vials)
Table 9. Global Antivenom Sales Market Share by Regions 2015-2020
Table 10. Global Antivenom Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Antivenom Revenue Market Share by Regions 2015-2020
Table 12. Top Antivenom Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Antivenom Key Drivers: Impact Analysis (2021-2026)
Table 15. Antivenom Key Challenges
Table 16. Main Points Interviewed from Key Antivenom Players: Views for Future
Table 17. Global Antivenom Sales by Manufacturers (2015-2020) (K Vials)
Table 18. Global Antivenom Sales Share by Manufacturers (2015-2020)
Table 19. Antivenom Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Antivenom Revenue Share by Manufacturers (2015-2020)
Table 21. Global Antivenom Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom as of 2019)
Table 23. Key Manufacturers Antivenom Average Selling Price (ASP) (2015-2020) (USD/Vial)
Table 24. Key Manufacturers Antivenom Plants/Factories Distribution
Table 25. Key Manufacturers Antivenom Area Served
Table 26. Date of Key Manufacturers Enter into Antivenom Market
Table 27. Key Manufacturers Antivenom Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Polyvalent antivenom Sales and Revenue (2015-2020) (K Vials) & (Million US$)
Table 30. Global Monovalent antivenom Sales and Revenue (2015-2020) (K Vials) & (Million US$)
Table 31. Global Antivenom Sales (K Vials) by Type (2015-2020)
Table 32. Global Antivenom Sales Share by Type (2015-2020)
Table 33. Global Antivenom Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Antivenom Price (K Vials) by Type (2015-2020)
Table 35. Global Antivenom Sales (K Vials) by Type (2021-2026)
Table 36. Global Antivenom Sales Share by Type (2021-2026)
Table 37. Global Antivenom Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Antivenom Revenue Share by Type (2021-2026)
Table 39. Global Antivenom Price (K Vials) by Type (2021-2026)
Table 40. Global Antivenom Sales (K Vials) by Application (2015-2020)
Table 41. Global Antivenom Sales Share by Application (2015-2020)
Table 42. Global Antivenom Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Antivenom Price by Application 2015-2020 (USD/Vial)
Table 44. Global Antivenom Sales by Application (2015-2020) (K Vials)
Table 45. Global Antivenom Sales Share by Application (2015-2020)
Table 46. Global Antivenom Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Antivenom Revenue Share by Application (2021-2026)
Table 48. Global Antivenom Price (K Vials) by Application (2021-2026)
Table 49. North America Antivenom Sales by Company (2015-2020) (K Vials)
Table 50. North America Antivenom Sales Market Share by Company (2015-2020)
Table 51. North America Antivenom Sales by Type (2015-2020) (K Vials)
Table 52. North America Antivenom Sales Market Share by Type (2015-2020)
Table 53. North America Antivenom Sales by Application (2015-2020) (K Vials)
Table 54. North America Antivenom Sales Market Share by Application (2015-2020)
Table 55. North America Antivenom Sales by Countries (2015-2020) (K Vials)
Table 56. North America Antivenom Sales Market Share by Countries (2015-2020)
Table 57. North America Antivenom Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Antivenom Revenue Market Share by Countries (2015-2020)
Table 59. Europe Antivenom Sales by Company (2015-2020) (K Vials)
Table 60. Europe Antivenom Sales Market Share by Company (2015-2020)
Table 61. Europe Antivenom Sales by Type (2015-2020) (K Vials)
Table 62. Europe Antivenom Sales Market Share by Type (2015-2020)
Table 63. Europe Antivenom Sales by Application (2015-2020) (K Vials)
Table 64. Europe Antivenom Sales Market Share by Application (2015-2020)
Table 65. Europe Antivenom Sales by Countries (2015-2020) (K Vials)
Table 66. Europe Antivenom Sales Market Share by Countries (2015-2020)
Table 67. Europe Antivenom Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Antivenom Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Antivenom Sales by Regions (2015-2020) (K Vials)
Table 70. Asia Pacific Antivenom Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Antivenom Sales by Type (2015-2020) (K Vials)
Table 72. Asia Pacific Antivenom Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Antivenom Sales by Application (2015-2020) (K Vials)
Table 74. Asia Pacific Antivenom Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Antivenom Sales by Countries (2015-2020) (K Vials)
Table 76. Asia Pacific Antivenom Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Antivenom Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Antivenom Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Antivenom Sales by Company (2015-2020) (K Vials)
Table 80. Latin America Antivenom Sales Market Share by Company (2015-2020)
Table 81. Latin America Antivenom Sales by Type (2015-2020) (K Vials)
Table 82. Latin America Antivenom Sales Market Share by Type (2015-2020)
Table 83. Latin America Antivenom Sales by Application (2015-2020) (K Vials)
Table 84. Latin America Antivenom Sales Market Share by Application (2015-2020)
Table 85. Latin America Antivenom Sales by Countries (2015-2020) (K Vials)
Table 86. Latin America Antivenom Sales Market Share by Countries (2015-2020)
Table 87. Latin America Antivenom Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Antivenom Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Antivenom Sales by Type (2015-2020) (K Vials)
Table 90. Middle East and Africa Antivenom Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Antivenom Sales by Application (2015-2020) (K Vials)
Table 92. Middle East and Africa Antivenom Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Antivenom Sales by Countries (2015-2020) (K Vials)
Table 94. Middle East and Africa Antivenom Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Antivenom Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Antivenom Revenue Market Share by Countries (2015-2020)
Table 97. CSL Behring Company Details
Table 98. CSL Behring Description and Business Overview
Table 99. CSL Behring Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 100. CSL Behring Antivenom Sales Growth Rate (2015-2020)
Table 101. CSL Behring Antivenom Sales Market Share in Global Market
Table 102. CSL Behring Recent Development
Table 103. Merck & Co. Company Details
Table 104. Merck & Co. Description and Business Overview
Table 105. Merck & Co. Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 106. Merck & Co. Antivenom Sales Growth Rate (2015-2020)
Table 107. Merck & Co. Antivenom Sales Market Share in Global Market
Table 108. Merck & Co. Recent Development
Table 109. BTG Plc Company Details
Table 110. BTG Plc Description and Business Overview
Table 111. BTG Plc Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 112. BTG Plc Antivenom Sales Growth Rate (2015-2020)
Table 113. BTG Plc Antivenom Sales Market Share in Global Market
Table 114. BTG Plc Recent Development
Table 115. Pfizer Company Details
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 118. Pfizer Antivenom Sales Growth Rate (2015-2020)
Table 119. Pfizer Antivenom Sales Market Share in Global Market
Table 120. Pfizer Recent Development
Table 121. Haffkine Bio-Pharmaceutical Corporation Company Details
Table 122. Haffkine Bio-Pharmaceutical Corporation Description and Business Overview
Table 123. Haffkine Bio-Pharmaceutical Corporation Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 124. Haffkine Bio-Pharmaceutical Corporation Antivenom Sales Growth Rate (2015-2020)
Table 125. Haffkine Bio-Pharmaceutical Corporation Antivenom Sales Market Share in Global Market
Table 126. Haffkine Bio-Pharmaceutical Corporation Recent Development
Table 127. Rare Disease Therapeutics Company Details
Table 128. Rare Disease Therapeutics Description and Business Overview
Table 129. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 130. Rare Disease Therapeutics Antivenom Sales Growth Rate (2015-2020)
Table 131. Rare Disease Therapeutics Antivenom Sales Market Share in Global Market
Table 132. Rare Disease Therapeutics Recent Development
Table 133. Flynn Pharma Company Details
Table 134. Flynn Pharma Description and Business Overview
Table 135. Flynn Pharma Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 136. Flynn Pharma Antivenom Sales Growth Rate (2015-2020)
Table 137. Flynn Pharma Antivenom Sales Market Share in Global Market
Table 138. Flynn Pharma Recent Development
Table 139. Vins Bioproducts Company Details
Table 140. Vins Bioproducts Description and Business Overview
Table 141. Vins Bioproducts Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 142. Vins Bioproducts Antivenom Sales Growth Rate (2015-2020)
Table 143. Vins Bioproducts Antivenom Sales Market Share in Global Market
Table 144. Vins Bioproducts Recent Development
Table 145. Bharat Serums and Vaccines Company Details
Table 146. Bharat Serums and Vaccines Description and Business Overview
Table 147. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 148. Bharat Serums and Vaccines Antivenom Sales Growth Rate (2015-2020)
Table 149. Bharat Serums and Vaccines Antivenom Sales Market Share in Global Market
Table 150. Bharat Serums and Vaccines Recent Development
Table 151. Serum Biotech Company Details
Table 152. Serum Biotech Description and Business Overview
Table 153. Serum Biotech Antivenom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 154. Serum Biotech Antivenom Sales Growth Rate (2015-2020)
Table 155. Serum Biotech Antivenom Sales Market Share in Global Market
Table 156. Serum Biotech Recent Development
Table 157. Antivenom Distributors List
Table 158. Antivenom Customers List
Table 159. Global Antivenom Sales Forecast 2021-2026 (K Vials) & (Million US$)
Table 160. Global Antivenom Sales Forecast by Type 2021-2026 (K Vials)
Table 161. Global Antivenom Sales Forecast by Application 2021-2026 (K Vials)
Table 162. Global Antivenom Sales Forecast by Regions 2021-2026 (K Vials)
Table 163. Global Antivenom Revenue Forecast by Regions 2021-2026 (Million US$)
Table 164. North America Antivenom Sales Forecast by Countries 2021-2026 (K Vials)
Table 165. North America Antivenom Revenue Forecast by Countries 2021-2026
Table 166. Europe Antivenom Sales Forecast by Countries 2021-2026 (K Vials)
Table 167. Europe Antivenom Revenue Market Share Forecast by Countries 2021-2026
Table 168. Asia Pacific Antivenom Sales Forecast by Regions 2021-2026 (K Vials)
Table 169. Asia Pacific Antivenom Revenue Forecast by Regions 2021-2026 (Million US$)
Table 170. Latin America Antivenom Sales Forecast by Countries 2021-2026 (K Vials)
Table 171. Latin America Antivenom Revenue Forecast by Countries 2021-2026 (Million US$)
Table 172. Middle East and Africa Antivenom Sales Forecast by Regions 2021-2026 (K Vials)
Table 173. Middle East and Africa Antivenom Revenue Forecast by Regions 2021-2026 (Million US$)
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenom Product Picture
Figure 2. Global Antivenom Sales Market Shar by Type 2015-2026
Figure 3. Polyvalent antivenom Figures
Figure 4. Monovalent antivenom Figures
Figure 5. Global Antivenom Sales Market Share by Application in 2019 & 2026
Figure 6. Retail Pharmacies Use Case
Figure 7. Hospitals Use Case
Figure 8. Others Use Case
Figure 9. Antivenom Report Years Considered
Figure 10. Global Antivenom Market Size 2015-2026 (Million US$)
Figure 11. Global Antivenom Sales 2015-2020 (K Vials)
Figure 12. Global Antivenom Market Size Market Share by Regions 2015-2020
Figure 13. Global Antivenom Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Antivenom Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Antivenom Sales in 2019
Figure 17. Antivenom Value Share by Manufacturers in 2019
Figure 18. Antivenom Revenue Share by Manufacturers In 2019
Figure 19. Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Antivenom Revenue Share by Type (2015-2020)
Figure 21. Global Antivenom Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Antivenom Market Share by Price Range (2015-2020)
Figure 23. Global Antivenom Revenue Share by Application (2015-2020)
Figure 24. Global Antivenom Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Antivenom Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 27. Canada Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 28. Europe Antivenom Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 30. France Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 31. U.K. Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 32. Italy Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 33. Russia Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 34. Asia Pacific Antivenom Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 36. Japan Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 37. South Korea Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 38. India Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 39. Australia Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 40. Taiwan Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 41. Indonesia Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 42. Thailand Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 43. Malaysia Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 44. Philippines Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 45. Vietnam Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 46. Latin America Antivenom Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 48. Brazil Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 49. Argentina Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 50. Middle East and Africa Antivenom Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 52. Saudi Arabia Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 53. U.A.E Antivenom Sales Growth Rate (2015-2020) (K Vials)
Figure 54. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. BTG Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Haffkine Bio-Pharmaceutical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Rare Disease Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Flynn Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Vins Bioproducts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Bharat Serums and Vaccines Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Serum Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Antivenom Value Chain
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. North America Antivenom Sales Growth Rate Forecast (2021-2026) (K Vials)
Figure 68. North America Antivenom Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 69. Europe Antivenom Sales Growth Rate Forecast (2021-2026) (K Vials)
Figure 70. Europe Antivenom Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Asia Pacific Antivenom Sales Growth Rate Forecast (2021-2026) (K Vials)
Figure 72. Asia Pacific Antivenom Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Latin America Antivenom Sales Growth Rate Forecast (2021-2026) (K Vials)
Figure 74. Latin America Antivenom Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Middle East and Africa Antivenom Sales Growth Rate Forecast (2021-2026) (K Vials)
Figure 76. Middle East and Africa Antivenom Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed